TipRanks
Alnylam Pharmaceuticals (MX:ALNY)
:ALNY

Compare Alnylam Pharma (ALNY) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$5550.00
$533.93B
36.02
-33.78%
18 Buy
4 Hold
0 Sell
Strong Buy
Arrowhead Pharmaceuticals
$88.88
$9.07B
-28.66
85.52%
11 Buy
1 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.07B
150.47
2.90%
17 Buy
5 Hold
0 Sell
Strong Buy
Ionis Pharmaceuticals
$63.57
$7.24B
-12.58
-36.35%
17 Buy
4 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$13.51
$1.72B
-3.65
-40.02%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.36B
-11.64
-23.88%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MX:ALNY
Alnylam Pharma
5,549.00
-2,831.00
-33.78%
ARWR
Arrowhead Pharmaceuticals
64.19
26.69
71.17%
BMRN
BioMarin Pharmaceutical
57.18
1.57
2.82%
IONS
Ionis Pharmaceuticals
43.54
-25.48
-36.92%
NTLA
Intellia Therapeutics
12.26
-8.28
-40.31%
CRSP
Crispr Therapeutics AG
55.43
-14.76
-21.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts